pecy7/pe conjugated anti-mouse cd150 (Thermo Fisher)
Structured Review

Pecy7/Pe Conjugated Anti Mouse Cd150, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pecy7/pe conjugated anti-mouse cd150/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function"
Article Title: Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function
Journal: iScience
doi: 10.1016/j.isci.2022.105171
Figure Legend Snippet: Treatment with Src inhibitor Saracatinib alters cell cycle status of HSCs in vivo (A) Schematic representation of the experiments performed to examine the effect of Saracatinib on HSC cycling and differentiation. Three doses of vehicle alone or Saracatinib (25 mg/kg), through oral gavage, were given on alternate days followed by hematology analysis of PB cells and flow cytometry of BM MNCs. (B) Quantitative RT-PCR analysis performed to quantify Sdf-1α transcript levels lin − CD45 − BM cells from vehicle or Saracatinib treated mice. Actb was used as the internal control and relative gene expression was plotted. n= 5, N= 10; Mann-Whitney test: ∗∗∗p < 0.001. (C) Comparison of SDF-1α secretion in the BM plasma of vehicle or Saracatinib treated mice. The samples from the two groups of mice were used for ELISA-based detection and quantification. Relative levels of protein in the two groups of samples is shown. n= 6, N= 12; t test: ∗∗∗p < 0.001. (D-F) Flow cytometry-based cell cycle analysis of the LSK cells from the BM MNCs of vehicle and Saracatinib treated mice. The LSK cells were analyzed for 7-AAD and Ki67 staining to quantify the proportion of cells in G 0 (D), G 1 (E), and SG 2 /M (F) stages of cell cycle. n= 6, N= 6-8; Mann Whitney test: ∗p < 0.05. (G) Flow cytometry plots for the analysis of cell cycle stages of HSC cells from the BM MNCs of vehicle and Saracatinib treated mice. The Sca-1 + c-kit + cells gated on lin − CD48 − cells (top panel) were further gated for CD150 + cells identifying the adult BM HSCs (middle panel). The HSCs were analyzed for DAPI and Ki67 staining to analyze the proportion of cells in different cell cycle stages. (H-J) Comparison of the proportion of HSCs in G 0 (H), G 1 (I), SG 2 /M (J) stages of cell cycle in control and Saracatinib treated mouse BM. n = 4, N= 8; Mann-Whitney test: ∗p < 0.05, ∗∗∗∗p < 0.0001, ns not significant. (K) Flow cytometry-based analysis of BM cells to quantify the frequency of BM HSCs in vehicle and Saracatinib treated mice. The BM lin - c-Kit + cells gated for Sca-1 + cells (LSK cells) were further analyzed for CD48 and CD150 expression for detecting LT-HSCs (CD48 − CD150 + cells; upper left), ST-HSCs (CD48 − CD150 - cells; bottom left), MPP2 (CD48 + CD150 + cells; upper right), and MPP3/4 (CD48 + CD150 - cells; bottom right). (L-O) Frequency of LT-HSCs (L), ST-HSCs (M), MPP2 (N), and MPP3/4 (O) among LSK cells in the BM of the mice treated with or without Saracatinib. Flow cytometry-based experiments were performed on BM MNCs, and quantifications were performed based on gates shown in adjacent panels (K). n= 9 Mann-Whitney test: ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001. (P) Comparison of the circulating hematopoietic progenitors in peripheral blood following Saracatinib treatment. Methylcellulose-based colony assays were performed to detect CFU-Cs in 200μL peripheral blood from Saracatinib treated or untreated mice. n = 3, t test: ns not significant p > 0.05. (Q-T) Flowcytometry-based detection of circulating hematopoietic stem and progenitor cells. Frequency of LT-HSCs (Q), ST-HSCs (R), MPP2 (S), and MPP3/4 (T) in the peripheral blood derived MNCs from mice treated with or without Saracatinib. n = 8; Mann-Whitney test: ns not significant p > 0.05.
Techniques Used: In Vivo, Flow Cytometry, Quantitative RT-PCR, Control, Gene Expression, MANN-WHITNEY, Comparison, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Cell Cycle Assay, Staining, Expressing, Derivative Assay
Figure Legend Snippet: Saracatinib treatment has no direct impact on HSCs ex vivo (A) Phase contrast images of the clusters of progeny from sorted LSK cells cultured in serum-free medium with SCF and TPO with or without Saracatinib (SRB; 50 and 100nM) after 5 days. (B) Expansion in the total number of cells after 5 days of culture. Sorted LSK cells were cultured with or without Saracatinib and harvested cells were counted using hemocytometer. n = 5, ns indicates not significant with p > 0.05, Student’s t test. (C) Comparison of LSK cell frequency in the cells harvested after 5 days of culture with or without Saracatinib. Harvested cells were used to perform flow cytometry-based phenotyping of cells and frequency of LSK cells was examined and compared between the samples. n = 5, ns indicates not significant with p > 0.05, Student’s t test. (D) Flowcytometry plots for analysis of the cell cycle stages of LSK cells from the harvested progeny of cultured hematopoietic progenitors. The lin − cells gated in the MNC population were analyzed for Sca-1 and c-kit expression to detect LSK cells. The LSK cells were further analyzed for CD48 and CD150 expression to detect LT-HSCs (CD48 − CD150 + cells; upper left), ST-HSCs (CD48 − CD150 - cells; bottom left), MPP2 (CD48 + CD150 + cells; upper right), and MPP3/4 (CD48 + CD150 - cells; bottom right). (E) The LSK cells identified in upper panel E, were further analyzed for DAPI and Ki67 staining to quantify the proportion of cells in G 0 , G 1 , and S-G 2 /M stages of cell cycle. (F) Comparison of the proportion of HSPCs (LSK cells) in various stages of cell cycle. The cells harvested after 5 days of culture with or without Saracatinib (50 and 100nM) were used for flow cytometry-based detection of various cell cycle stages based on Ki67 and DAPI staining. n = 6, ns indicates not significant with p > 0.05 using Student’s t test. (G) Frequency of LT-HSCs, ST-HSCs, MPP2s, and MPP3/4s in the cells harvested after 5 days of culture of LSK cells with or without Saracatinib. Flow cytometry-based experiments were performed on the harvested cells, and quantifications were performed based on gates shown in D lower panel. n = 5, ns indicates data not significant with p > 0.05, Student’s t test. (H) Flow cytometry analysis of the progeny of LSK cells cultured for 5 days with or without Saracatinib. To identify the myeloid progenitors MNCs gated on lin − cells were first analyzed for c-kit and Sca-1 expression. The lin - c-Kit + Sca-1 - cells were analyzed for the expression of CD16/32 and CD34 to identify MEPs, GMPs and CMPs. (I) The lymphoid progenitor cells (CLPs) in the progeny of LSK cells after 5 days of culture was identified as CD127 lo CD135 + cells within the lin - c-Kit lo Sca-1 + population. (J) Frequency of CLPs, GMPs, CMPs, and MEPs (D) in the cells harvested after 5 days of culture started with sorted BM derived LSK cells with or without Saracatinib (0, 50 and 100nM). Flow cytometry-based experiments were performed on the harvested cells, and quantifications were performed based on gates shown in panels H and I. n = 6-7 mice, ns indicates data not significant with p > 0.05, Student’s t test.
Techniques Used: Ex Vivo, Cell Culture, Comparison, Flow Cytometry, Expressing, Staining, Derivative Assay
Figure Legend Snippet: Faster recovery of hematopoietic system in mice following Saracatinib treatment (A) Schematic representation of radiation recovery experiments performed on vehicle and Saracatinib treated mice. Following sub-lethal irradiation, PB counts were counted weekly to compare the radiation recovery in the two groups of mice. After eight weeks, experiments were terminated and flow cytometry analysis was performed on BM cells. (B-J) Number of WBCs (B), lymphocytes (C), granulocytes (D), monocytes (E), eosinophils (F), platelets (G), RBCs (H), hematocrit values (HCT; I), and hemoglobin levels (HGB; J) were compared between control and Saracatinib injected groups, for a period of up to eight weeks. (K-O) Comparison of recovery of BM hematopoietic system from radiation injury in control versus Saracatinib treated mice. After 8 weeks of irradiation, the mice were sacrificed and BM mononuclear cells were analyzed for HSPC sub-populations. Frequency of LSK cells (K) and the four sub-populations, based on the expression of SLAM markers CD150 and CD48, were examined; CD150 − CD48 + LSK (MPP3/4; L), CD150 + CD48 + LSK (MPP2; M), CD150 − CD48 − LSK (ST-HSCs; N) and CD150 − CD48 + LSK (LT-HSCs; O) cells were identified and quantified. Data obtained from 10-12 independent biological replicates, was plotted as mean ± SEM ∗p < 0.05, ∗∗p < 0.01 by Mann-Whitney test.
Techniques Used: Irradiation, Flow Cytometry, Control, Injection, Comparison, Expressing, MANN-WHITNEY
Figure Legend Snippet:
Techniques Used: Purification, Virus, Recombinant, Western Blot, Membrane, Enzyme-linked Immunosorbent Assay, Bicinchoninic Acid Protein Assay, Isolation, cDNA Synthesis, SYBR Green Assay, CRISPR, Knock-Out, Gene Expression, Plasmid Preparation, Software
